This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hongyo, T. Articles by Nomura, T. Search for Related Content PubMed PubMed Citation Articles by Hongyo, T. Articles by Nomura, T.

Specific c-kit Mutations in Sinonasal Natural Killer/T-Cell Lymphoma in China and Japan¹

Departments of Radiation Biology [T. H., M. S., R. B., T. N.], Pathology [T. L., K. A.], and Hemato-Oncology [H. I., Y. K.], Faculty of Medicine, Osaka University, Osaka 565-0871, Japan

Sinonasal lymphoma is one of the constituents of lethal midline granuloma, which is a clinical term for progressive, destructive lesions affecting the midline of the face. The majority of sinonasal lymphomas, especially those showing polymorphous patterns of proliferation and thus termed polymorphic reticulosis, recently were categorized as sinonasal natural killer/T-cell lymphomas. They are more prevalent in Asia than Europe or North America and are associated with EBV infection. Twenty-three cases with sinonasal natural killer/T-cell lymphomas were collected from two high-incidence regions: Beijing, China (14 cases) and Osaka, Japan (9 cases). c-kit mutations were analyzed on paraffin-embedded specimens by PCR-single-strand conformation polymorphism followed by direct sequencing; the c-kit proto-oncogene encodes a receptor of tyrosine kinase, which plays an important role in the regulation of normal and neoplastic hematopoiesis by the interaction with its specific ligand, termed stem cell factor. Twelve single nucleotide substitution mutations were seen in 23 cases. Ten of 14 Chinese cases (71.4%) had mutations at exon 11 or exon 17, whereas only two of nine Japanese cases (22.2%) had mutations, showing a significant difference in frequency between Chinese and Japanese cases. Furthermore, seven of eight mutations (92%) in exon 17 occurred at codon 825 and three of four mutations (75%) in exon 11 occurred at codon 561. Such a specificity has not been reported before, and these results, taken together, suggest that location-specific differences in etiological factors cause specific mutations in c-kit gene.

This article has been cited by other articles:

				J. P. Zappulla, P. Dubreuil, S. Desbois, S. Letard, N. B. Hamouda, M. Daeron, G. Delsol, M. Arock, and R. S. Liblau Mastocytosis in mice expressing human Kit receptor with the activating Asp816Val mutation J. Exp. Med., December 19, 2005; 202(12): 1635 - 1641. [Abstract] [Full Text] [PDF]

				H. Sihto, M. Sarlomo-Rikala, O. Tynninen, M. Tanner, L. C. Andersson, K. Franssila, N. N. Nupponen, and H. Joensuu KIT and Platelet-Derived Growth Factor Receptor Alpha Tyrosine Kinase Gene Mutations and KIT Amplifications in Human Solid Tumors J. Clin. Oncol., January 1, 2005; 23(1): 49 - 57. [Abstract] [Full Text] [PDF]

				J. Lennartsson, T. Jelacic, D. Linnekin, and R. Shivakrupa Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit Stem Cells, January 1, 2005; 23(1): 16 - 43. [Abstract] [Full Text] [PDF]

				C. L. Corless, J. A. Fletcher, and M. C. Heinrich Biology of Gastrointestinal Stromal Tumors J. Clin. Oncol., September 15, 2004; 22(18): 3813 - 3825. [Abstract] [Full Text] [PDF]

				K. Kemmer, C. L. Corless, J. A. Fletcher, L. McGreevey, A. Haley, D. Griffith, O. W. Cummings, C. Wait, A. Town, and M. C. Heinrich KIT Mutations Are Common in Testicular Seminomas Am. J. Pathol., January 1, 2004; 164(1): 305 - 313. [Abstract] [Full Text] [PDF]

				H-P Horny, K Lange, K Sotlar, and P Valent Increase of bone marrow lymphocytes in systemic mastocytosis: reactive lymphocytosis or malignant lymphoma? Immunohistochemical and molecular findings on routinely processed bone marrow biopsy specimens J. Clin. Pathol., August 1, 2003; 56(8): 575 - 578. [Abstract] [Full Text] [PDF]

				K. Sotlar, L. Escribano, O. Landt, S. Mohrle, S. Herrero, A. Torrelo, U. Lass, H.-P. Horny, and B. Bultmann One-Step Detection of c-kit Point Mutations Using Peptide Nucleic Acid-Mediated Polymerase Chain Reaction Clamping and Hybridization Probes Am. J. Pathol., March 1, 2003; 162(3): 737 - 746. [Abstract] [Full Text] [PDF]

				D. Frost, J. Lasota, and M. Miettinen Gastrointestinal Stromal Tumors and Leiomyomas in the Dog: A Histopathologic, Immunohistochemical, and Molecular Genetic Study of 50 Cases Vet. Pathol., January 1, 2003; 40(1): 42 - 54. [Abstract] [Full Text] [PDF]

				M. J. Frost, P. T. Ferrao, T. P. Hughes, and L. K. Ashman Juxtamembrane Mutant V560GKit Is More Sensitive to Imatinib (STI571) Compared with Wild-Type c-Kit Whereas the Kinase Domain Mutant D816VKit Is Resistant Mol. Cancer Ther., October 1, 2002; 1(12): 1115 - 1124. [Abstract] [Full Text] [PDF]

				M. C. Heinrich, C. D. Blanke, B. J. Druker, and C. L. Corless Inhibition of KIT Tyrosine Kinase Activity: A Novel Molecular Approach to the Treatment of KIT-Positive Malignancies J. Clin. Oncol., March 15, 2002; 20(6): 1692 - 1703. [Abstract] [Full Text] [PDF]